Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lazarus

Showing results (781-790 of 881) with videos related to

Pageof 89
Sort By:
Bone Marrow Transplantation|April 28, 2015
Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcomeS D Goyal, M-J Zhang, H-L Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2008
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR)Hillard M Lazarus, Jeanette Carreras, Christian Boudreau, et al.
Blood|March 3, 2021
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysisScott R Goldsmith, Muhammad Bilal Abid, Jeffery J Auletta, et al.
Blood Advances|September 1, 2019
Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1Celalettin Ustun, Soyoung Kim, Min Chen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 14, 2019
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR studySeema Naik, Marcie Riches, Parameswaran Hari, et al.
Bone Marrow Transplantation|November 18, 2014
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donorV Bachanova, L J Burns, T Wang, et al.
The New England Journal of Medicine|March 16, 2012
Prognostic relevance of integrated genetic profiling in acute myeloid leukemiaJay P Patel, Mithat Gönen, Maria E Figueroa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphomaTimothy S Fenske, Parameswaran N Hari, Jeanette Carreras, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2018
Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple MyelomaSathish Gopalakrishnan, Anita D'Souza, Emma Scott, et al.
Blood|November 29, 2002
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphomaJohn E Levine, Richard E Harris, Fausto R Loberiza, et al.
Pageof 89

Showing results (781-790 of 881) with videos related to

Sort By:
Pageof 89
Bone Marrow Transplantation|April 28, 2015
Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcomeS D Goyal, M-J Zhang, H-L Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2008
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR)Hillard M Lazarus, Jeanette Carreras, Christian Boudreau, et al.
Blood|March 3, 2021
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysisScott R Goldsmith, Muhammad Bilal Abid, Jeffery J Auletta, et al.
Blood Advances|September 1, 2019
Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1Celalettin Ustun, Soyoung Kim, Min Chen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 14, 2019
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR studySeema Naik, Marcie Riches, Parameswaran Hari, et al.
Bone Marrow Transplantation|November 18, 2014
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donorV Bachanova, L J Burns, T Wang, et al.
The New England Journal of Medicine|March 16, 2012
Prognostic relevance of integrated genetic profiling in acute myeloid leukemiaJay P Patel, Mithat Gönen, Maria E Figueroa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphomaTimothy S Fenske, Parameswaran N Hari, Jeanette Carreras, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2018
Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple MyelomaSathish Gopalakrishnan, Anita D'Souza, Emma Scott, et al.
Blood|November 29, 2002
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphomaJohn E Levine, Richard E Harris, Fausto R Loberiza, et al.
Pageof 89